MA (EU) number 
(Invented) 
name 
Strength  Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1507/001  Spikevax   
--¹ 
EU/1/20/1507/002  Spikevax   
--² 
EU/1/20/1507/003  Spikevax   
--² 
EU/1/20/1507/004  Spikevax  
--³ 
bivalent 
Original/Omicron 
BA.1 
EU/1/20/1507/005  Spikevax  
--³ 
bivalent 
Original/Omicron 
BA.1 
EU/1/20/1507/006  Spikevax  
--⁴ 
bivalent 
Original/Omicron 
BA.4-5 
EU/1/20/1507/007  Spikevax  
--³ 
bivalent 
Original/Omicron 
BA.1 
EU/1/20/1507/008  Spikevax  
--³ 
bivalent 
Original/Omicron 
BA.1 
EU/1/20/1507/009  Spikevax  
--⁴ 
bivalent 
Original/Omicron 
BA.4-5 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
vial (glass or 
cyclic olefin 
polymer) 
vial (glass or 
cyclic olefin 
polymer) 
pre-filled 
syringe (cyclic 
olefin 
polymer) 
vial (glass or 
cyclic olefin 
polymer) 
vial (glass or 
cyclic olefin 
polymer) 
vial (glass or 
cyclic olefin 
polymer) 
pre-filled 
syringe (cyclic 
olefin 
polymer) 
vial (glass) 
5 ml (10 or 20 
doses) 
2.5 ml (5 or 10 
doses) 
0.5 ml (1 dose) 
5 ml (10 or 20 
doses) 
2.5 ml (5 or 10 
doses) 
2.5 ml (5 or 10 
doses) 
0.5 ml (1 dose) 
10 multidose 
vials (100 or 200 
doses)  
10 multidose 
vials (50 or 100 
doses)  
10 pre-filled 
syringes (10 
doses)  
10 multidose 
vials (100 or 200 
doses)  
10 multidose 
vials (50 or 100 
doses)  
10 multidose 
vials (50 or 100 
doses)  
10 pre-filled 
syringes (10 
doses)  
0.5 ml (1 dose) 
10 single dose 
vials (10 doses)  
Dispersion for 
injection 
Intramuscular 
use 
vial (glass) 
0.5 ml (1 dose) 
10 single dose 
vials (10 doses)  
1 
 
 
 
MA (EU) number 
(Invented) 
name 
Strength  Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1507/010  Spikevax  
--⁴ 
EU/1/20/1507/011 
bivalent 
Original/Omicron 
BA.4-5 
Spikevax XBB.1.5 
--5 
EU/1/20/1507/012 
Spikevax XBB.1.5 
--5 
EU/1/20/1507/013 
Spikevax XBB.1.5 
--5 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
pre-filled 
syringe (cyclic 
olefin 
polymer) 
vial (glass) 
Dispersion for 
injection 
Intramuscular 
use 
Dispersion for 
injection 
Intramuscular 
use 
vial (cyclic 
olefin 
polymer) 
vial (glass) 
0.5 ml (1 dose) 
2.5 ml (5 or 10 
doses) 
2.5 ml (5 or 10 
doses) 
0.5 ml (1 dose) 
EU/1/20/1507/014 
Spikevax XBB.1.5 
--5 
Dispersion for 
injection 
Intramuscular 
use 
vial (glass) 
0.5 ml (1 dose) 
10 pre-filled 
syringes (10 
doses)  
10 multidose 
vials (50 or 100 
doses) 
10 multidose 
vials (50 or 100 
doses) 
1 single dose vial 
(1 dose) 
10 single dose 
vials (10 doses) 
1 pre-filled 
syringe (1 dose) 
EU/1/20/1507/015 
Spikevax XBB.1.5 
--5 
Dispersion for 
injection 
Intramuscular 
use 
EU/1/20/1507/016 
Spikevax XBB.1.5 
--5 
Dispersion for 
injection 
Intramuscular 
use 
pre-filled 
syringe 
(cyclic olefin 
polymer) 
pre-filled 
syringe 
(cyclic olefin 
polymer) 
0.5 ml (1 dose) 
0.5 ml (1 dose) 
10 pre-filled 
syringes (10 
doses) 
--¹ 
One dose (0.5 mL) contains 100 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles).  
One dose (0.25 mL) contains 50 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles) 
Elasomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Original). 
--² 
One dose (0.5 mL) contains 50 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One dose (0.25 mL) contains 25 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
Elasomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Original). 
--³ 
One dose (0.5 mL) contains 25 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles) and 25 micrograms of 
imelasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
One dose (0.25 mL) contains 12.5 micrograms of elasomeran and 12.5 micrograms of imelasomeran, a COVID-19 mRNA Vaccine (embedded in lipid 
nanoparticles). 
Elasomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Original). 
Imelasomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Omicron BA.1). 
--⁴ 
One dose (0.5 mL) contains 25 micrograms of elasomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles) and 25 micrograms of 
davesomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
One dose (0.25 mL) contains 12.5 micrograms of elasomeran and 12.5 micrograms of davesomeran, a COVID-19 mRNA Vaccine (embedded in lipid 
nanoparticles). 
Elasomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Original). 
Davesomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Omicron BA.4-5). The S proteins of the SARS-CoV-2 Omicron variant lineages BA.4 
and BA.5 are identical. 
--5 
One dose (0.5 mL) contains 50 micrograms of andusomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
One dose (0.25 mL) contains 25 micrograms of andusomeran, a COVID-19 mRNA Vaccine (embedded in lipid nanoparticles). 
Andusomeran is a single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA 
3 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
templates, encoding the viral spike (S) protein of SARS-CoV-2 (Omicron XBB.1.5). 
4 
 
 
